Bioxytran, Inc
BIXT· OTC
BIXTBioxytran, Inc
Filed Apr 19, 2024 · 10-Q · 19 days after period end · 0001493152-24-015358
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$800.33K | -$785.08K | -$963.39K | -$1.78M |
| EPS Diluted | $0.00 | -$0.01 | — | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed Apr 19, 2024 · 19 d after period end
